RGCNasdaq
Regencell Bioscience Holdings Ltd
Healthcare·Healthcare·Causeway Bay, Hong Kong
Key Financials
Market Cap
$8.0B
Cash
$2.4M
Quarterly Burn
—
Runway
—
Revenue
—
Institutional Holdings
Source: SEC Form 13F · as of Mar 2026Institutional holders
31
Total value held
$17.9M
| Holder | Shares | Value |
|---|---|---|
| geode capital management, llc | 415,569 | $10.6M |
| susquehanna international group, llp | 72,700 | $1.8M |
| marex group plc | 63,200 | $1.6M |
| citadel advisors llc | 34,300 | $872K |
| jane street group, llc | 28,000 | $712K |
| morgan stanley | 20,078 | $511K |
| bank of america corp /de/ | 17,172 | $437K |
| state street corp | 11,851 | $301K |
| legal & general group plc | 9,903 | $252K |
| lpl financial llc | 8,596 | $219K |
Showing top 10 of 31 institutional holders of Regencell Bioscience Holdings Ltd. Sign up for the full 13F holder list and quarter-by-quarter ownership history.
·CEO: Mr. Yat-Gai Au
Frequently asked questions
What is Regencell Bioscience Holdings Ltd's market capitalization?
Regencell Bioscience Holdings Ltd's market capitalization is approximately $8.0B.
Who is the CEO of Regencell Bioscience Holdings Ltd?
Mr. Yat-Gai Au is the chief executive officer of Regencell Bioscience Holdings Ltd (RGC).
Get the full picture on Regencell Bioscience Holdings Ltd
Deep pipeline analysis, financial trends, AI-powered investment signals, and real-time catalyst alerts.